Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Julia Korell"'
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 12, Iss 6, Pp 758-769 (2023)
Abstract BI 730357 is investigated as an oral treatment of plaque psoriasis. We analyzed the impact of three dosage regimens on the Psoriasis Area and Severity Index (PASI) response with modeling based on phase I and II data from 109 healthy subjects
Externí odkaz:
https://doaj.org/article/9f3709a3d792455c8294af56375c3e83
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 9, Iss 2, Pp 87-95 (2020)
We describe a parametric time‐to‐event model for idiopathic pulmonary fibrosis (IPF) exacerbations and identify predictors of exacerbation risk using data obtained for the tyrosine‐kinase inhibitor nintedanib in two phase III studies (INPULSIS
Externí odkaz:
https://doaj.org/article/dc0a8deb55fd4386b42f8aeaef39bd7a
Publikováno v:
European Journal of Clinical Pharmacology. 74:593-599
Schizophrenia is a common disease which is commonly managed using antipsychotic medications (APS). Inadequate response and lack of adherence often prevent optimal therapeutic effectiveness. Monitoring APS concentrations can be useful to help improve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34bdca7fa1687fb1797b51e5af59c0c1
https://doi.org/10.1007/s00228-018-2419-3
https://doi.org/10.1007/s00228-018-2419-3
Publikováno v:
European Journal of Pharmaceutical Sciences. 109:S154-S160
Respiratory syncytial virus (RSV) causes acute lower respiratory tract infections, and is a major cause of hospital admissions and death in young children. Limited treatments currently exist that can prevent or minimise exacerbation of the disease. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f355778a458893a28bc71b011b364382
https://doi.org/10.1016/j.ejps.2017.05.070
https://doi.org/10.1016/j.ejps.2017.05.070
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology. 6:589-595
Schizophrenia is a common disease managed by a range of interventions, with the primary treatment being antipsychotic medications (APS). Inadequate response, lack of adherence, and/or adverse events often prevent optimal therapeutic effects or therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::891be8e751c72914694fc8699dd342f3
https://doi.org/10.1002/psp4.12217
https://doi.org/10.1002/psp4.12217
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology
CPT: Pharmacometrics & Systems Pharmacology, Vol 9, Iss 2, Pp 87-95 (2020)
CPT: Pharmacometrics & Systems Pharmacology, Vol 9, Iss 2, Pp 87-95 (2020)
We describe a parametric time‐to‐event model for idiopathic pulmonary fibrosis (IPF) exacerbations and identify predictors of exacerbation risk using data obtained for the tyrosine‐kinase inhibitor nintedanib in two phase III studies (INPULSIS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0eb9bc1dc67c084e179cc327480f973
https://pubmed.ncbi.nlm.nih.gov/31919989
https://pubmed.ncbi.nlm.nih.gov/31919989
Publikováno v:
60. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V..
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d9bc9f695ea83642c0a040809c6aa30
https://doi.org/10.1055/s-0039-1678098
https://doi.org/10.1055/s-0039-1678098
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology. 6:573-575
Schizophrenia is a common disease, characterized by progressive functional decline exacerbated by psychotic relapses that often result from a lack of full adherence to antipsychotic (APS) medication. Although atypical APS medications do not have clea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95cc69d1d1d1e99d80ff307e036b4077
https://doi.org/10.1002/psp4.12212
https://doi.org/10.1002/psp4.12212
Publikováno v:
Revue des Maladies Respiratoires. 36:A135-A136
Introduction La FPI est une pneumopathie parenchymateuse chronique, progressive d’issue fatale. L’exploration des facteurs predictifs de mortalite dans la FPI est importante sur le plan clinique et pour le developpement de medicaments. La FDA a r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38510af951cb216f6b80e645454677f9
https://doi.org/10.1016/j.rmr.2018.10.287
https://doi.org/10.1016/j.rmr.2018.10.287
Autor:
Mei Zhang, Lisa K. Stamp, Jill Drake, Stephen B. Duffull, Judith M. Dalrymple, Murray L. Barclay, Julia Korell
Publikováno v:
British Journal of Clinical Pharmacology. 77:493-497
AimTo assess the similarities in intracellular pharmacokinetics (PK) of methotrexate (MTX) in red blood cells (RBCs) and other cell lines. MethodsThree previously published PK models for intracellu ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a789f3fa80f24cc7f7ffdf176bbef718
https://doi.org/10.1111/bcp.12209
https://doi.org/10.1111/bcp.12209